ÇÐȸ¼Ò°³ ÇÐȸÁÖ°ü½Ã»ó

4. ÀÏõ±â³ä°­Á (Ilchun Memorial Lecture)

 
Á¦28ȸ ¼ö»óÀÚ (2023³â) Á¦27ȸ ¼ö»óÀÚ (2022³â) Á¦26ȸ ¼ö»óÀÚ (2021³â) Á¦25ȸ ¼ö»óÀÚ (2020³â)
Á¦24ȸ ¼ö»óÀÚ (2019³â) Á¦23ȸ ¼ö»óÀÚ (2018³â) Á¦22ȸ ¼ö»óÀÚ (2017³â) Á¦21ȸ ¼ö»óÀÚ (2016³â)
Á¦20ȸ ¼ö»óÀÚ (2015³â) Á¦19ȸ ¼ö»óÀÚ (2014³â) Á¦18ȸ ¼ö»óÀÚ (2013³â) Á¦17ȸ ¼ö»óÀÚ (2012³â)
Á¦16ȸ ¼ö»óÀÚ (2011³â) Á¦15ȸ ¼ö»óÀÚ (2010³â) Á¦14ȸ ¼ö»óÀÚ (2009³â) Á¦13ȸ ¼ö»óÀÚ (2008³â)
Á¦12ȸ ¼ö»óÀÚ (2007³â) Á¦11ȸ ¼ö»óÀÚ (2006³â) Á¦10ȸ ¼ö»óÀÚ (2005³â) Á¦9ȸ ¼ö»óÀÚ (2004³â)
Á¦8ȸ ¼ö»óÀÚ (2003³â) Á¦7ȸ ¼ö»óÀÚ (2002³â) Á¦6ȸ ¼ö»óÀÚ (2000³â) Á¦5ȸ ¼ö»óÀÚ (1998³â)
Á¦4ȸ ¼ö»óÀÚ (1997³â) Á¦3ȸ ¼ö»óÀÚ (1996³â) Á¦2ȸ ¼ö»óÀÚ (1995³â) Á¦1ȸ ¼ö»óÀÚ (1994³â)
±è¿µÅ (¼­¿ï´ëÇб³)

Dr. Kim is a professor of Thoracic and Cardiovascular Surgery, Seoul National University College of Medicine. After received his medical degree from Seoul National University College of Medicine and residency training in Thoracic and Cardiovascular Surgery at Seoul National University Hospital, he was trained as a clinical fellow of Advanced General Thoracic Surgery at Mayo Clinic, Rochester, MN. Since he was appointed as a lecturer in 1996, he spent most of his academic career at Seoul National University. He served as chairman of the Department of Thoracic and Cardiovascular Surgery from 2012 to 2020; and served as a director of the Lung Cancer Center, Seoul National University Cancer Hospital. In academic society, he is serving as a chairman of the Korean Association for Lung Cancer, the Korean Cancer Association board. Internationally, he works as an associated editor for the Journal of Thoracic Oncology, Disease of the Esophagus, and Innovation. He received Dr. C. Lillehei Merit Award for Excellence in Clinical Research and the Johnson & Johnson Medical Award, Korean Society of Thoracic and Cardiovascular Surgery. Being interested in clinical and basic researches of thoracic malignancies, he published more than 300 papers in peer-reviewed journals, including Cell, Nature Genetics, Genomic Research, Cancer Immunology Research, Journal of Thoracic Oncology, and Journal of Thoracic and Cardiovascular Surgery.

Representative papers
1. Lee, J.J., et al., Tracing Oncogene Rearrangements in the Mutational History of Lung Adenocarcinoma. Cell, 2019. 177(7): p. 1842-1857.e21.
2. Seo, J.S., et al., Whole Exome and Transcriptome Analyses Integrated with Microenvironmental Immune Signatures of Lung Squamous Cell Carcinoma. Cancer Immunol Res, 2018. 6(7): p. 848-859.
3. Seo, J.S., et al., Comprehensive analysis of the tumor immune micro-environment in non-small cell lung cancer for efficacy of checkpoint inhibitor. Sci Rep, 2018. 8(1): p. 14576.
4. Jang, H.J., et al., Transcriptome-based molecular subtyping of non-small cell lung cancer may predict response to immune checkpoint inhibitors. J Thorac Cardiovasc Surg, 2020. 159(4): p. 1598-1610.e3.
5. Im, S.W., et al., A newly developed capture-based sequencing panel for genomic assay of lung cancer. Genes Genomics, 2020. 42(7): p. 751-759.

   

Àüü¸Þ´º

´Ý±â

Ä«Å×°í¸®º° Àüü ¸Þ´º¸¦ È®ÀÎÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.